Sullivan Lynne Marie 4
4 · Unity Biotechnology, Inc. · Filed Aug 6, 2024
Insider Transaction Report
Form 4
Sullivan Lynne Marie
CFO & Head of Corp. Dev.
Transactions
- Sale
Common Stock, $0.0001 par value
2024-08-02$1.53/sh−139$213→ 56,061 total
Footnotes (3)
- [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- [F2]Includes Restricted Stock Units which vest over time measured from the grant date.
- [F3]Represents adjusted total that includes an aggregate of 23,515 shares purchased under the Unity Biotechnology, Inc. 2018 Employee Stock Purchase Plan on May 15, 2023 and May 15, 2024 in transactions exempt from reporting pursuant to Rule 16b-3(c).